Operation Moonshot featured theanalyticalscientist.com Below is a quick overview of the full article. In the summer of 2020, the UK’s Department of Health and Social Care (DHSC) launched Operation Moonshot to support innovative SARS-CoV-2 diagnostic approaches. This collaboration between academia, industry, and the NHS aimed to develop an LC-MS/MS-based test for detecting low levels of […]
Waters Corporation and Biosero® have partnered to bring together the Andrew+ Pipetting Robot™ with Green Button Go® software, enabling scientists to fully automate their sample preparation workflows. As scientific innovation continues to rapidly advance, enabling scientists with equally innovative tools is a must. Traditional laboratory operations can be limited by unconnected devices and software platforms, […]
Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media
Download(opens in new window) News Summary: Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses. New pre-developed LC-MS analytical workflows make it even easier for bioprocess engineers with limited LC-MS experience to accelerate upstream process development […]
The next-generation pipetting technology enhances reproducibility and simplifies complex and time-consuming manual workflows SANTA CLARA, California, Oct. 26, 2020 /PRNewswire/ — Based on its recent analysis of the North American pipetting robot market for life sciences, Frost & Sullivan recognizes Andrew Alliance, a Waters Company, with the 2020 North American Product Leadership Award. Andrew Alliance’s liquid […]
“The acquisition of Andrew Alliance broadens our technology portfolio to include advanced robotics and software that will positively impact our customers’ workflows across pharmaceuticals, life sciences and materials science markets,” commented Chris O’Connell, Chairman and Chief Executive Officer of Waters Corporation. “This move also demonstrates Waters’ commitment to deploy capital to growth-oriented acquisitions that reinforce our specialty strategy and enhance our core business.”
Andrew Alliance Announces Partnership With Brooks Life Sciences Enabling Their Consumables to be Added to Its Groundbreaking OneLab Software
“We are excited to announce this strategic relationship with Andrew Alliance that will make it much easier for researchers to take greater advantage of the wide range of cutting-edge consumables that we supply to the life science industry,” said Tracy Andrews, Senior Product Manager of Brooks Life Sciences 4titude range. “This means that researchers will be able to more easily, and quickly, set up their liquid handling workflows in OneLab, be they for PCR, NGS or imaging, speeding up both their research and their ability to disseminate the work of other research groups.” “What makes this especially powerful, if that these protocols can then be executed on either Andrew Alliance’s automated liquid handling solutions, increasing productivity and reducing the risk of error.”
“We are excited to announce this exciting relationship with Andrew Alliance,” said Arcis CEO Peter Whitehurst. “The Andrew+ robot combined with our Arcis reagents represent a hands-free solution for stabilizing and preparing samples for RNA or DNA analysis, especially in infectious disease detection workflows, where speed is a key requirement.”
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Sample tracking on Andrew automation brings added levels of traceability to a wide variety of low to medium throughout applications
Andrew Alliance S.A., the robotics company that is improving repeatability with an innovative approach to liquid handling with conventional laboratory pipettes, and technology company Ziath Ltd, today announced a collaboration agreement to integrate barcode reading into Andrew Alliance’s software package. Under the co-marketing agreement, Andrew Alliance’s will integrate Ziath’s DataPaq™ Mirage 2D barcode rack scanner and other devices with their OneLab software platform and associated hardware, bringing sample tracking capability to a large number of applications.
Andrew Alliance S.A., the robotics company that is improving repeatability with an innovative approach to liquid handling using conventional laboratory pipettes, and Waters Corporation (NYSE: WAT), today announced a new strategic partnership agreement to improve laboratory operations in the field of liquid chromatography and mass spectrometry (LC-MS). Through this partnership, Andrew Alliance aims to benefit from Waters Corporation’s expertise as a leader in the LC-MS field, and in doing so drive even greater product innovation.
Andrew Alliance S.A., the robotics company that is improving laboratory workflow execution through the development of a cloud-based software solution (OneLab) together with connected devices, and biotechnology company, Valitacell Ltd., today announced a collaboration agreement to integrate Valitacell’s cell line development applications into OneLab. This exciting partnership will combine Valitacell’s novel analytical technologies with Andrew Alliance’sconnected devices, and will have a transformative impact on the manufacture of biologic drugs. Valitacell’s intelligent analytical technologies enable data driven decisions which, combined with automation and connectivity, will help streamline the biomanufacturing industries’ processes, to improve manufacturing productivity, speed-up time to market and reduce the cost of goods overall.
Macherey-Nagel GmbH & Co. KG and Andrew Alliance today announced they have signed an agreement stating that they are working together to develop an automated solution for the preparation of transfection grade plasmid DNA.
GENEVA, Feb. 2, 2019 /PRNewswire/ — Andrew Alliance S.A., the robotics company that is improving laboratory workflow execution through the development of a cloud-based software solution (OneLab) and connected devices, today announced that it is has been awarded CO2 Neutral Certification, based on the internationally recognised PAS2060 standard.
Andrew Alliance today announced a $14 million investment by several of the leading life sciences enterprises, including Tecan Group, the Waters Corporation, Inpeco, Rancilio Cube, Sam Eletr Trust and Omega Funds.
Andrew Alliance is pleased to announce that our CEO, Piero Zucchelli, has been selected to join the SLAS Technology Editorial Board. SLAS Technology is a peer-reviewed and multi-disciplinary journal devoted to the advancement of life science technologies, with specific emphasis on scientific and technical advances that improve life science R&D. SLAS Technology recently doubled its impact factor to 2.85, and became one of the leading journals in the field. Andrew Alliance is proud of the opportunity to broadly support innovation in life science R&D with the goal of narrowing the gap between research achievements and available commercial solutions. We invite anybody in the Andrew Alliance community to contact [email protected] for possible interest in submission for publication.
Waters Corporation (NYSE:WAT) and Andrew Alliance today announced they have signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS. Under the co-marketing agreement, Waters will combine its existing Glycoworks™ RapiFluor-MS™ (RFMS) N-Glycan Kits with an Andrew pipetting robot that will allow laboratories to meet the demands on them for glycan profiling while improving the accuracy and precision of LC and LC-MS results.
Andrew Pipetting Robot Featured in Waters Corporation ASMS Poster- Successfully Automating Glycan Analysis
Andrew Alliance was recently featured in a poster presentation from Waters Corporation during ASMS 2017 in Indianapolis. The poster discusses and presents the successful preparation of labeled N-glycans by means of using the Andrew robot in high sensitivity LC-MS analysis. The poster concludes the Andrew Alliance pipetting system can successfully and reproducibly perform GlycoWorks with RapiFluor-MS N-Glycan rapid labeling procedures. Use of the pipetting robot allows the analyst to free time and complete two jobs in parallel while maintaining high quality and reproducible scientific results
Andrew Alliance has been awarded the Red Herring Europe recognition, a prestigious award that positions the company among the top 100 emerging private organizations across all industries on the continent.
Lumigen Inc. (A Beckman Coulter Company) presented a poster demonstrating the use of Andrew with their SPARCL Pharmacokinetic Immunoassay kits at the AAPS NBC event in San Diego. The poster summarizes Andrew’s accuracy and error free execution of the SPARCL kits leading to improved efficiency, reduced PK assay development and cost, all while increasing profitability. The specific poster relates to measuring IgG drug concentration in a pre-clinical setting.
BOSTON, Oct. 15, 2014 /PRNewswire/ — RoboBusiness (Oct. 15-17, Hynes Convention Center, Boston), the leading business development event for the global robotics market, is thrilled to announce the winners of the 2014 Game Changer Awards, honoring the robotics industry’s remarkable technical accomplishments and their makers.
Andrew Alliance announced today that the Company will be opening up a Boston office in Copley Square. The Company also announced the closing of a series B financing round from Omega Funds, a leading global healthcare fund specializing in late stage life science investments. The Omega investment will enable Andrew Alliance to expand the reach of its well-received robots, by enabling new developments and the establishment of commercial operations in the U.S. market.
Instrument Business Outlook (IBO) today announced the winners of the 19th annual IBO Design Awards for excellence in the industrial design of analytical instruments, portable analytical instruments and laboratory equipment. The winners of the 2013 Awards demonstrate how industrial design can improve a product’s functionality and the end-user’s experience.
More than 66 new products were launched at SLAS 2013, and three companies were selected by a panel of judges to receive the SLAS New Product Award (NPA) Designation, recognizing the best of what’s new on the exhibit floor. Each year, a panel of SLAS judges scrutinizes new products and services on display at the SLAS Exhibition and awards up to three SLAS NPA Designations.